keyword
https://read.qxmd.com/read/38646735/opioid-use-prescribing-and-fatal-overdose-patterns-among-racial-ethnic-minorities-in-the-united-states-a-scoping-review-and-conceptual-risk-environment-model
#1
REVIEW
Jerel M Ezell, Mai T Pho, Babatunde P Ajayi, Elinor Simek, Netra Shetty, Dawn A Goddard-Eckrich, Ricky N Bluthenthal
ISSUES: To date, there has been no synthesis of research addressing the scale and nuances of the opioid epidemic in racial/ethnic minority populations in the United States that considers the independent and joint impacts of dynamics such as structural disadvantage, provider bias, health literacy, cultural norms and various other risk factors. APPROACH: Using the "risk environment" framework, we conducted a scoping review on PubMed, Embase and Google Scholar of peer-reviewed literature and governmental reports published between January 2000 and February 2024 on the nature and scale of opioid use, opioid prescribing patterns, and fatal overdoses among racial/ethnic minorities in the United States, while also examining macro, meso and individual-level risk factors...
April 22, 2024: Drug and Alcohol Review
https://read.qxmd.com/read/38646089/pharmacokinetics-informed-neural-network-for-predicting-opioid-administration-moments-with-wearable-sensors
#2
JOURNAL ARTICLE
Bhanu Teja Gullapalli, Stephanie Carreiro, Brittany P Chapman, Eric L Garland, Tauhidur Rahman
Long-term and high-dose prescription opioid use places individuals at risk for opioid misuse, opioid use disorder (OUD), and overdose. Existing methods for monitoring opioid use and detecting misuse rely on self-reports, which are prone to reporting bias, and toxicology testing, which may be infeasible in outpatient settings. Although wearable technologies for monitoring day-to-day health metrics have gained significant traction in recent years due to their ease of use, flexibility, and advancements in sensor technology, their application within the opioid use space remains underexplored...
February 2024: Proceedings of the ... AAAI Conference on Artificial Intelligence
https://read.qxmd.com/read/38645066/nor-laam-loaded-plga-microparticles-for-treating-opioid-use-disorder
#3
Diane Ingabire, Chaolong Qin, Tuo Meng, Aji Alex Moothendathu Raynold, Hadi Sudarjat, E Andrew Townsend, Rudra Pangeni, Sagun Poudel, Michelle Arriaga, Long Zhao, Woon N Chow, Matthew Banks, Qingguo Xu
The treatment landscape for opioid use disorder (OUD) faces challenges stemming from the limited efficacy of existing medications, poor adherence to prescribed regimens, and a heightened risk of fatal overdose post-treatment cessation. Therefore, there is a pressing need for innovative therapeutic strategies that enhance the effectiveness of interventions and the overall well-being of individuals with OUD. This study explored the therapeutic potential of nor-Levo-α-acetylmethadol (nor-LAAM) to treat OUD...
April 11, 2024: bioRxiv
https://read.qxmd.com/read/38643071/does-psychological-distress-predict-risk-of-orthopaedic-surgery-and-postoperative-opioid-prescribing-in-patients-with-hip-pain-a-retrospective-study
#4
JOURNAL ARTICLE
Kent F Sutton, Grant H Cabell, Lucas W Ashley, Trevor A Lentz, Brian D Lewis, Steven A Olson, Richard C Mather
BACKGROUND: Clinicians and public health professionals have allocated resources to curb opioid over-prescription and address psychological needs among patients with musculoskeletal pain. However, associations between psychological distress, risk of surgery, and opioid prescribing among those with hip pathologies remain unclear. METHODS: Using a retrospective cohort study design, we identified patients that were evaluated for hip pain from January 13, 2020 to October 27, 2021...
April 20, 2024: BMC Musculoskeletal Disorders
https://read.qxmd.com/read/38642543/mapping-a-moral-panic-news-media-narratives-and-medical-expertise-in-public-debates-on-safer-supply-diversion-and-youth-drug-use-in-canada
#5
JOURNAL ARTICLE
Liam Michaud, Gillian Kolla, Katherine Rudzinski, Adrian Guta
The ongoing overdose and drug toxicity crisis in North America has contributed momentum to the emergence of safer supply prescribing and programs in Canada as a means of providing an alternative to the highly volatile unregulated drug supply. The implementation and scale-up of safer supply have been met with a vocal reaction on the part of news media commentators, conservative politicians, recovery industry representatives, and some prominent addiction medicine physicians. This reaction has largely converged around several narratives, based on unsubstantiated claims and anecdotal evidence, alleging that safer supply programs are generating a "new opioid epidemic", reflecting an emerging alignment among key institutional and political actors...
April 19, 2024: International Journal on Drug Policy
https://read.qxmd.com/read/38641919/common-outpatient-diagnoses-and-associated-treatments-logged-by-osteopathic-medical-students-within-a-geriatric-population
#6
JOURNAL ARTICLE
Hannah C Coulson, Miriam Brown, Kyle Burke, Emma Griffith, Victoria Shadiack, Harold R Garner, Jaime A Foushee
CONTEXT: Clinical clerkships provide osteopathic medical students the opportunity to participate in the diagnosis and treatment of commonly encountered medical conditions. Appropriate management of these conditions may include pharmacotherapy and/or nonpharmacologic interventions, such as osteopathic manipulative treatment (OMT). Opportunities may exist to expand the utilization of OMT in the management of common conditions, particularly for geriatric patients, who are at increased risk for adverse outcomes from pharmacologic treatments...
April 22, 2024: Journal of osteopathic medicine
https://read.qxmd.com/read/38641873/opioid-risk-tool-in-hospital-opioid-exposure-and-opioid-demand-predict-pain-outcomes-following-traumatic-injury
#7
JOURNAL ARTICLE
Danielle A Kessler, Heather E Webber, Constanza de Dios, Jin H Yoon, Joy M Schmitz, Scott D Lane, John A Harvin, Angela M Heads, Charles E Green, Shweta Kapoor, Angela L Stotts, Kandice L Motley, Robert Suchting
Prescribed opioids are a mainstay pain treatment after traumatic injury, but a subgroup of patients may be at risk for continued opioid use. We evaluated the predictive utility of a traditional screening tool, the Opioid Risk Tool (ORT), and two other measures: average in-hospital milligram morphine equivalents (MME) per day and an assessment of opioid demand in predicting pain outcomes. Assessments of pain-related outcomes (pain intensity, interference, injury-related stress, and need for additional pain treatment) were administered at 2 weeks and 12 months post-discharge in a sample of 34 patients hospitalized for traumatic injury...
April 19, 2024: Journal of Health Psychology
https://read.qxmd.com/read/38641055/composition-of-buprenorphine-prescribing-networks-in-medicaid-and-association-with-quality-of-care
#8
JOURNAL ARTICLE
Jane M Zhu, Christina Charlesworth, Bradley Stein, Coleman Drake, Daniel Polsky, Todd Korthuis, K John McConnell
INTRODUCTION: Despite Medicaid's outsized role in delivering and financing medications for opioid use disorder (MOUD), little is known about the extent to which buprenorphine prescriber networks vary across Medicaid health plans, and whether network characteristics affect quality of treatment received. In this observational cross-sectional study, we used 2018-2019 Medicaid claims in Oregon to assess network variation in the numbers and types of buprenorphine prescribers, as well as the association of prescriber and network characteristics with quality of care...
April 17, 2024: J Subst Use Addict Treat
https://read.qxmd.com/read/38641053/use-of-harm-reduction-strategies-among-individuals-with-a-history-of-incarceration-a-short-report-using-baseline-data-collected-from-the-stamina-clinical-trial
#9
JOURNAL ARTICLE
Grant Victor, Bradley Ray, Dennis P Watson
BACKGROUND: Due to the considerably heightened risk of overdose immediately following jail or prison release, expansion of harm reduction interventions for citizens returning to the community after an incarceration episode should be of utmost concern. However, there are no studies examining the adoption and use of harm reduction among this population. This short report examines the use of individual-level harm reduction strategies (HRS) among people who use drugs, comparing those who have lifetime histories of incarceration with those who do not...
April 17, 2024: J Subst Use Addict Treat
https://read.qxmd.com/read/38638745/factors-affecting-upper-limb-fracture-opioid-requirements
#10
JOURNAL ARTICLE
James Zhang, Florence Bradshaw, Michal Duchniewicz, Fernanda W Fernandes, Rahul Geetala, Matjia Krkovic
Introduction Understanding the different opioid pain relief requirements between patients with upper limb fractures can be useful in forming specific evidence-based guidelines and balancing patient-clinician prescribing discussions with opioid stewardship. We investigated the predictors for opioid requirements in upper limb fractures. Methods We retrospectively investigated all upper limb fractures from the shoulder to the wrist treated at a major trauma center from January 2015 to January 2022. The data collected consisted of fracture location, demographics, comorbidities, and management options...
March 2024: Curēus
https://read.qxmd.com/read/38636807/a-pilot-randomized-controlled-trial-of-medication-adherence-therapy-psychosocial-leverage-using-a-significant-other-mat-plus-for-individuals-on-extended-release-naltrexone
#11
JOURNAL ARTICLE
Kevin Wenzel, Julia Thomas, Jennifer Carrano, Jennifer Stidham, Marc Fishman
BACKGROUND: Extended-release naltrexone (XR-NTX) is an important treatment option for individuals with opioid use disorder (OUD) and/or alcohol use disorder (AUD). However, problems with retention are a major barrier to its overall effectiveness, and interventions to improve adherence are underdeveloped. The purpose of this study was to pilot test the MAT-PLUS intervention, which combines assertive outreach and involvement of a treatment significant other (TSO) to improve adherence to XR-NTX...
April 15, 2024: J Subst Use Addict Treat
https://read.qxmd.com/read/38634339/implementation-of-opioid-safety-efforts-influence-of-academic-detailing-on-adverse-outcomes-among-patients-in-the-veterans-health-administration
#12
JOURNAL ARTICLE
Emily C Williams, Madeline C Frost, Mark Bounthavong, Amy T Edmonds, Marcos K Lau, E Jennifer Edelman, Michael A Harvey, Melissa L D Christopher
BACKGROUND: The Veterans Health Administration (VA) implemented academic detailing (AD) to support safer opioid prescribing and overdose prevention initiatives. METHODS: Patient-level data were extracted monthly from VA's electronic health record to evaluate whether AD implementation was associated with changes in all-cause mortality, opioid poisoning inpatient admissions, and opioid poisoning emergency department (ED) visits in an observational cohort of patients with long-term opioid prescriptions (≥45-day supply of opioids 6 months prior to a given month with ≤15 days between prescriptions)...
April 18, 2024: Subst Use Addctn J
https://read.qxmd.com/read/38631907/general-practitioners-risk-literacy-and-real-world-prescribing-of-potentially-hazardous-drugs-a-cross-sectional-study
#13
JOURNAL ARTICLE
Odette Wegwarth, Tammy C Hoffmann, Ben Goldacre, Claudia Spies, Helge A Giese
BACKGROUND: Overuse of medical care is a pervasive problem. Studies using hypothetical scenarios suggest that physicians' risk literacy influences medical decisions; real-world correlations, however, are lacking. We sought to determine the association between physicians' risk literacy and their real-world prescriptions of potentially hazardous drugs, accounting for conflicts of interest and perceptions of benefit-harm ratios in low-value prescribing scenarios. SETTING AND SAMPLE: Cross-sectional study-conducted online between June and October 2023 via field panels of Sermo (Hamburg, Germany)-with a convenience sample of 304 English general practitioners (GPs)...
April 17, 2024: BMJ Quality & Safety
https://read.qxmd.com/read/38631841/restrictive-use-of-restraints-and-delirium-duration-in-the-intensive-care-unit-r2d2-icu-protocol-for-a-french-multicentre-parallel-group-open-label-randomised-controlled-trial
#14
JOURNAL ARTICLE
Romain Sonneville, Camille Couffignal, Florian Sigaud, Virginie Godard, Juliette Audibert, Damien Contou, Adam Celier, Michel Djibre, Julien Schmidt, Pierre Jaquet, Armand Mekontso Dessap, Claire Bourel, Romane Bellot, Carine Roy, Fariza Lamara, Fatiha Essardy, Jean-François Timsit, Renaud Cornic, Lila Bouadma
INTRODUCTION: Physical restraint (PR) is prescribed in patients receiving invasive mechanical ventilation in the intensive care unit (ICU) to avoid unplanned removal of medical devices. However, it is associated with an increased risk of delirium. We hypothesise that a restrictive use of PR, as compared with a systematic use, could reduce the duration of delirium in ICU patients receiving invasive mechanical ventilation. METHODS AND ANALYSIS: The Restrictive use of Restraints and Delirium Duration in ICU (R2D2-ICU) study is a national multicentric, parallel-group, randomised (1:1) open-label, controlled, superiority trial, which will be conducted in 10 ICUs...
April 17, 2024: BMJ Open
https://read.qxmd.com/read/38631722/designing-a-primary-care-pharmacist-led-review-for-people-treated-with-opioids-for-persistent-pain-a-multi-method-qualitative-study
#15
JOURNAL ARTICLE
Charlotte Woodcock, Nicola Cornwall, Lisa Dikomitis, Sarah A Harrisson, Simon White, Toby Helliwell, Roger Knaggs, Eleanor Hodgson, Tamar Pincus, Miriam Santer, Christian Mallen, Julie Ashworth, Clare Jinks
BACKGROUND: Opioids are frequently prescribed for persistent non-cancer pain despite limited evidence of long-term effectiveness and risk of harm. Evidence-based interventions to address inappropriate opioid prescribing are lacking. AIM: To explore perspectives of people living with persistent pain to understand barriers and facilitators in reducing opioids in the context of a pharmacist-led primary care review, and identify review components and features for optimal delivery...
April 17, 2024: BJGP Open
https://read.qxmd.com/read/38629664/medication-recommendations-for-treatment-of-lumbosacral-radiculopathy-a-systematic-review-of-clinical-practice-guidelines
#16
REVIEW
Morgan R Price, Kaelyn E Mead, Diana M Cowell, Alyssa M Troutner, Tyler E Barton, Sheryl A Walters, Clinton J Daniels
OBJECTIVE: The purpose of this systematic review was to ascertain guideline-recommended pharmaceutical approaches to lumbosacral radicular symptoms, assess the quality of the clinical practice guidelines (CPGs) with the Appraisal of Guidelines for Research and Evaluation II (AGREE II) tool, and qualitatively synthesize the guideline recommendations. LITERATURE SURVEY: Literature searches were performed in PubMed, Cochrane Database of Systematic Reviews, Index to Chiropractic Literature, Allied and Complementary Medicine Database (AMED), Cumulative Index for Nursing and Allied Health Literature (CINAHL), and Physiotherapy Evidence Database (PEDro)...
April 17, 2024: PM & R: the Journal of Injury, Function, and Rehabilitation
https://read.qxmd.com/read/38629002/the-effect-of-nonsteroidal-anti-inflammatory-drugs-on-union-rates-following-joint-arthrodesis-a-meta-analysis
#17
REVIEW
Emerson T Rowe, Julian Takagi-Stewart, Sina Ramtin, Margaret Pennington, Asif M Ilyas
Nonsteroidal anti-inflammatory drugs (NSAIDs) are among the most widely used and prescribed medications because of their important role in reducing inflammation and pain, in addition to their non-addictive properties and safety profiles. However, some studies have documented an association between NSAIDs and delayed union or nonunion of joint arthrodesis procedures due to a potential inhibition of the bone's inflammatory healing response. As a result, some orthopedic surgeons hesitate to prescribe NSAIDs after an arthrodesis procedure...
March 2024: Curēus
https://read.qxmd.com/read/38628605/preventable-suicides-involving-medicines-a-systematic-case-series-of-coroners-reports-in-england-and-wales
#18
JOURNAL ARTICLE
G Anthony, J K Aronson, R Brittain, C Heneghan, G C Richards
BACKGROUND: In England and Wales coroners have a duty to write a report, called a Prevention of Future Deaths report or PFD, when they believe that actions should be taken to prevent future deaths. Coroners send PFDs to individuals and organisations who are required to respond within 56 days. Despite the increase in mental health concerns and growing use of medicines, deaths reported by coroners that have involved medicine-related suicides had not yet been explored. Therefore, this study aimed to systematically assess coroners' PFD reports involving suicides in which a medicine caused or contributed to the death to identify lessons for suicide prevention...
June 2024: Public health in practice
https://read.qxmd.com/read/38627812/patterns-and-trends-of-medicinal-poisoning-substances-a-population-based-cohort-study-of-injuries-in-0-11-year-old-children-from-1998-2018
#19
JOURNAL ARTICLE
Edward G Tyrrell, Elizabeth Orton, Laila J Tata, Denise Kendrick
BACKGROUND: There have been sharp increases in antidepressant and opioid prescriptions over the last 10 years, as well as increased over-the-counter medicine availability. However, the impact on childhood medicinal poisonings rates, particularly by socioeconomic deprivation is unclear. This study reports population level medicinal poisoning substance patterns in England among children aged 0-11 years, helping inform safety advice and poisoning prevention interventions. METHODS: An open cohort study of 1,489,620 0-11 year olds was conducted from 1998 to 2018, using the Clinical Practice Research Datalink, to examine inpatient hospital admissions for poisoning...
April 16, 2024: Archives of Public Health, Archives Belges de Santé Publique
https://read.qxmd.com/read/38626996/barriers-and-facilitators-for-family-physicians-prescribing-opioid-agonist-therapy-in-saskatchewan
#20
JOURNAL ARTICLE
Teresa Nguyen, Julia Bareham, Katelyn Halpape
OBJECTIVE: To explore barriers and facilitators for family physicians in Saskatchewan prescribing opioid agonist therapy (OAT). DESIGN: Self-administered postal survey. SETTING: Family medicine practices in Saskatchewan. PARTICIPANTS: A total of 218 Saskatchewan family physicians who were not authorized to prescribe OAT as of June 2022. MAIN OUTCOME MEASURES: Descriptive and inferential statistics of physicians' self-reported barriers to and facilitators of prescribing OAT for opioid use disorder (OUD)...
April 2024: Canadian Family Physician Médecin de Famille Canadien
keyword
keyword
106875
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.